Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms

Astrid M. van Huizen, S.P. Menting, Rolland Gyulai, Lars Iversen, G. E. van der Kraaij, Maritza A. Middelkamp‐Hup, Richard B. Warren, Phyllis I. Spuls, Adrián A. Schejtman, Alexander Egeberg, Alireza Firooz, Alur S. Kumar, Amanda Oakley, Amy Foulkes, Andréa Machado Coelho Ramos, Anne‐Claire Fougerousse, Antoanela Čarija, Ayşe Akman-Karakaş, Barbara Horváth, Béata Fábos, Benjamín Hidalgo Matlock, Birgitta Wilson Claréus, Carla Castro, ,

Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms

Abstract

Discussion(0)

Related publications

Methotrexate for psoriasis in the era of biological therapy

The use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom

Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy

Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis

International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis